Details for Patent: 10,300,229
✉ Email this page to a colleague
Which drugs does patent 10,300,229 protect, and when does it expire?
Patent 10,300,229 protects XHANCE and is included in one NDA.
This patent has thirty patent family members in sixteen countries.
Summary for Patent: 10,300,229
| Title: | Nasal delivery devices |
| Abstract: | A nasal delivery device for and method of delivering substance to a nasal airway of a subject, the delivery device comprising: a nosepiece (117) for fitting to a nasal cavity of a subject; a mouthpiece (119) into which the subject in use exhales; a delivery unit, which comprises an actuation part which is manually displaceable to actuate the delivery unit to deliver substance from the nosepiece; and a valve assembly (127) which is fluidly connected to the nosepiece and the mouthpiece, wherein the valve assembly comprises a body element (128) and a valve element (131) which is movably disposed to the body element between closed and open configurations by manual displacement of the actuation part of the delivery unit to provide for an air flow through the nosepiece simultaneously with delivery of substance. |
| Inventor(s): | Djupesland; Per Gisle (Oslo, NO), Leclerc; Michael (Cranston, RI), Mahmoud; Ramy A. (Skillman, NJ), Siwinski; Shane (Providence, RI), Gordon; Joseph (Mansfield, MA), Fisk; Justin (Providence, RI) |
| Assignee: | OptiNose AS (Oslo, NO) |
| Application Number: | 14/380,827 |
|
Patent Claim Types: see list of patent claims | Use; Delivery; Device; |
Drugs Protected by US Patent 10,300,229
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Optinose Us Inc | XHANCE | fluticasone propionate | SPRAY, METERED;NASAL | 209022-001 | Sep 18, 2017 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | METHOD OF DELIVERING FLUTICASONE PROPIONATE TO A NASAL AIRWAY | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 10,300,229
| PCT Information | |||
| PCT Filed | February 25, 2013 | PCT Application Number: | PCT/EP2013/053746 |
| PCT Publication Date: | August 29, 2013 | PCT Publication Number: | WO2013/124491 |
International Family Members for US Patent 10,300,229
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2013223972 | ⤷ Try a Trial | |||
| Canada | 2865352 | ⤷ Try a Trial | |||
| China | 104428025 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
